A study of lymph node ratio in stage IV colorectal cancer

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Derwinger, Kristoffer ^a   Gustavsson, Bengt ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL STATUS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; CELL DIFFERENTIATION; COLORECTAL TUMOR; DRUG EFFECT; PATHOLOGY; SURVIVAL RATE;

AGED; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 60649085176     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-127     Document Type: Article

References (23)

1. Health SNBo Incidence of cancer in Sweden 2001
2. Greene FL Staging of colon and rectal cancer: From endoscopy to molecular markers Surg Endosc 2006, 20(Suppl 2):S475-478 10.1007/ s00464-006-0005-8 16544060
3. Daniels IR Fisher SE Heald RJ Moran BJ Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: A review of the recent evidence Colorectal Dis 2007, 9:290-301 10.1111/j.1463-1318.2006.01116.x 17432979
4. UICC/AJCC TNM Classification of Malignant Tumors, fifth edition (1997) 1997
5. Yun HR Lee WY Lee OS Cho YB Yun SH Chun HK The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status Int J Colorectal Dis 2007, 22(11):1301-1310 10.1007/s00384-007-0315-x 17486358
6. Kehoe J Khatri VP Staging and prognosis of colon cancer Surg Oncol Clin N Am 2006, 15:129-146 10.1016/j.soc.2005.08.006 16389154
7. Dhar DK Yoshimura H Kinukawa N Maruyama R Tachibana M Kohno H Kubota H Nagasue N Metastatic lymph node size and colorectal cancer prognosis J Am Coll Surg 2005, 200:20-28 10.1016/j.jamcollsurg.2004.09.037 15631916
8. Berberoglu U Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer Hepatogastroenterology 2004, 51:1689-1693 15532806
9. Berger AC Sigurdson ER LeVoyer T Hanlon A Mayer RJ Macdonald JS Catalano PJ Haller DG Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol 2005, 23:8706-8712 10.1200/JCO.2005.02.8852 16314630
10. Lee HY Choi HJ Park KJ Shin JS Kwon HC Roh MS Kim C Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma Ann Surg Oncol 2007, 14(5):1712-1717 10.1245/s10434-006-9322-3 17253102
11. oncology Rco Regional guidelines for colorectal cancer 2006
12. Ragnhammar P Hafstrom L Nygren P Glimelius B A systematic overview of chemotherapy effects in colorectal cancer Acta Oncol 2001, 40:282-308 10.1080/02841860151116367 11441937
13. Turrini O Viret F Guiramand J Lelong B Bege T Delpero JR Strategies for the treatment of synchronous liver metastasis Eur J Surg Oncol 2007, 33:735-740 17400418
14. Iizasa T Suzuki M Yoshida S Motohashi S Yasufuku K Iyoda A Shibuya K Hiroshima K Nakatani Y Fujisawa T Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer Ann Thorac Surg 2006, 82:254-260 10.1016/j.athoracsur.2006.02.027 16798225
15. Compton CC Fielding LP Burgart LJ Conley B Cooper HS Hamilton SR Hammond ME Henson DE Hutter RV Nagle RB Nielsen ML Sargent DJ Taylor CR Welton M Willett C Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 2000, 124:979-994 10888773
16. Fakih MG Padmanabhan A CEA monitoring in colorectal cancer. What you should know Oncology (Williston Park) 2006, 20:579-587 discussion 588, 594, 596 passim. 16773844
17. Mori T Hirota T Ohashi Y Kodaira S Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer Dis Colon Rectum 2006, 49:982-992 10.1007/ s10350-006-0531-4 16625329
18. Kuo LJ Leu SY Liu MC Jian JJ Hongiun Cheng S Chen CM How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003, 46:1646-1652 10.1007/BF02660770 14668590
19. Scoggins CR Meszoely IM Blanke CD Beauchamp RD Leach SD Nonoperative management of primary colorectal cancer in patients with stage IV disease Ann Surg Oncol 1999, 6:651-657 10.1007/s10434-999-0651-x 10560850
20. Jones OM John SK Horseman N Lawrance RJ Fozard JB Cause and place of death in patients dying with colorectal cancer Colorectal Dis 2007, 9:253-257 10.1111/j.1463-1318.2006.01131.x 17298624
21. Choi JS Choo SW Park KB Shin SW Yoo SY Kim JH Do YS Interventional management of malignant colorectal obstruction: Use of covered and uncovered stents Korean J Radiol 2007, 8:57-63 17277564
22. Derwinger K Carlsson G Gustavsson B A study of lymph node ratio as a prognostic marker in colon cancer Eur J Surg Oncol 2008, 34:771-775 18079086
23. Poston GJ Figueras J Giuliante F Nuzzo G Sobrero AF Gigot JF Nordlinger B Adam R Gruenberger T Choti MA Bilchik AJ Van Cutsem EJ Chiang JM D'Angelica MI Urgent need for a new staging system in advanced colorectal cancer J Clin Oncol 2008, 26:4828-4833 10.1200/ JCO.2008.17.6453 18711170